May 7, 2019

Terren Peizer
Chairman and Chief Executive Officer
BioVie Inc.
11601 Wilshire Boulevard, Suite 1100
Los Angeles, CA 90025

       Re: BioVie Inc.
           Registration Statement on Form S-1
           Filed April 30, 2019
           File No. 333-231136

Dear Mr. Peizer:

       We have limited our review of your registration statement to those
issues we have
addressed in our comment. In our comment, we may ask you to provide us with
information so
we may better understand your disclosure.

       Please respond to this letter by amending your registration statement
and providing the
requested information. If you do not believe our comment applies to your facts
and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

       After reviewing any amendment to your registration statement and the
information you
provide in response to the comment, we may have additional comments.

Registration Statement on Form S-1 filed on April 30, 2019

Cover page

1.     We note your disclosure of a recent sale price of your common stock on
the OTCQB
       Marketplace. Please expand your disclosure to state the expected
offering price per share
       or method by which the offering price will be determined. Refer to
Instruction 2 to Item
       501(b)(3) of Regulation S-K.
        We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence of
action by the staff.
 Terren Peizer
BioVie Inc.
May 7, 2019
Page 2



       Refer to Rules 460 and 461 regarding requests for acceleration. Please
allow adequate
time for us to review any amendment prior to the requested effective date of
the registration
statement.

       Please contact Christine Westbrook at 202-551-5019 or Erin Jaskot at
202-551-3442 with
any other questions.



                                                           Sincerely,
FirstName LastNameTerren Peizer
                                                           Division of
Corporation Finance
Comapany NameBioVie Inc.
                                                           Office of Healthcare
& Insurance
May 7, 2019 Page 2
cc:       Mitchell S. Nussbaum, Esq.
FirstName LastName